Skip to main content

Safety evaluation of the food enzyme 1,4‐α‐glucan branching enzyme from the non‐genetically modified Geobacillus thermodenitrificans strain TRBE14

EFSA Journal logo
Wiley Online Library

Meta data

Note The full opinion will be published in accordance with Article 12 of Regulation (EC) No 1331/2008 once the decision on confidentiality will be received from the European Commission.

Abstract

The food enzyme 1,4‐α‐glucan branching enzyme ((1–4)‐α‐d‐glucan:(1–4)‐α‐d‐glucan 6‐α‐d‐[(1–4)‐α‐d‐glucano]‐transferase; EC 2.4.1.18) is produced with the non‐genetically modified Geobacillus thermodenitrificans strain TRBE14 by Nagase (Europa) GmbH. The production strain has been shown to qualify for the qualified presumption of safety (QPS) approach. The food enzyme is intended to be used in cereal‐based processes, baking processes as well as meat and fish processing. Dietary exposure to the food enzyme–total organic solids (TOS) was estimated to be up to 0.29 mg TOS/kg body weight (bw) per day in European populations. Toxicological studies were not considered necessary given the QPS status of the production strain and the nature of the manufacturing process. A search for the similarity of the amino acid sequence of the food enzyme to known allergens was made and no match was found. The Panel noted that the food enzyme contains lysozyme, a known allergen. Therefore, allergenicity cannot be excluded. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use.